What did the Supreme Court rule in Monsanto v. Durnell?

In a 7-2 decision issued June 25, 2026, the Supreme Court ruled that the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) expressly preempts state-law failure-to-warn claims against pesticide manufacturers when the EPA has not required the warning in question. The case arose from a Missouri man who developed non-Hodgkin lymphoma after two decades of Roundup use and won a $1.25 million jury verdict that the Supreme Court reversed.

How does the Supreme Court ruling relate to the Farm Bill pesticide liability fight?

In April 2026, the House stripped a pesticide liability shield from the Farm Bill in a 280-142 vote, preserving state-court access for cancer plaintiffs. The Supreme Court's June 2026 ruling in Monsanto v. Durnell achieved the same outcome through federal preemption doctrine rather than legislation. Because the ruling establishes FIFRA preemption as a matter of constitutional interpretation, it is harder to reverse than a statutory provision — Congress could repeal a Farm Bill liability clause, but overturning a Supreme Court preemption doctrine requires either a new case or legislation amending the underlying federal law.

Does the ruling apply to pesticides other than Roundup?

Yes. FIFRA governs all pesticides registered for use in the United States, not just glyphosate. The preemption logic established in Monsanto v. Durnell applies to any pesticide whose EPA-approved label omits a health warning that a plaintiff argues should have been included. This includes pesticides with fluorinated chemistries and PFAS-based compounds approved under FIFRA registration. Legal analysts have also noted the ruling's potential reach into other federally regulated labeling regimes, including medical devices and food-contact substances.

What legal options remain for Roundup cancer plaintiffs?

Failure-to-warn claims in state court are now largely blocked by FIFRA preemption. Remaining options include design defect claims, which argue the product was negligently formulated rather than inadequately labeled; Bayer's proposed $7.25 billion class-action settlement, with a final approval hearing scheduled for July 9, 2026; congressional legislation to amend FIFRA and reverse the preemption ruling by statute; and EPA rulemaking — if the agency's revised glyphosate evaluation, expected fall 2026, requires a cancer warning label, the preemption argument would invert in plaintiffs' favor.

Is glyphosate a known carcinogen?

The scientific and regulatory picture is contested. The International Agency for Research on Cancer classified glyphosate as probably carcinogenic to humans in 2015. The U.S. EPA concluded in 2020 that it is unlikely to cause cancer when used as directed, though the Ninth Circuit Court of Appeals found that analysis inadequately explained and ordered a revised assessment. That revised EPA evaluation is expected in fall 2026. The regulatory disagreement between IARC and the EPA is the central dispute underlying the Monsanto v. Durnell litigation.

Illustration of a figure in judicial robes pouring Roundup glyphosate over a food pyramid labeled with glyphosate warnings across every food group

Pesticide Makers Couldn’t Get Immunity Through Congress. Supreme Court Delivers It Anyway.

Q: What is FIFRA preemption?

FIFRA preemption is the legal principle, now affirmed by the Supreme Court, that federal pesticide labeling law supersedes state-level requirements, including those imposed through civil litigation. If the EPA approves a pesticide label without a health warning, no state can effectively mandate one through regulation or a jury verdict. EPA label approval now functions as a ceiling of accountability rather than a floor.

June 26, 2026 · 8 min read

On April 30, 2026, a bipartisan House majority stripped a pesticide liability shield from the Farm Bill in a 280-142 vote, preserving the right of cancer plaintiffs to sue over Roundup’s alleged risks. Food and health advocates called it a victory. Fifty-six days later, the Supreme Court largely undid it.

On June 25, 2026, the court ruled 7-2 in Monsanto Co. v. Durnell that federal pesticide law bars state-level failure-to-warn lawsuits against Roundup’s manufacturer. The mechanism was different from the Farm Bill provision. The outcome was functionally identical: tens of thousands of cancer plaintiffs can no longer bring failure-to-warn claims in state court. What grassroots organizing blocked through Congress, the Trump administration achieved through the courts.

What the Court Decided in Monsanto v. Durnell

The case: John Durnell, a Missouri resident, was exposed to Roundup for more than two decades while serving as his neighborhood association’s designated spray applicator. He developed non-Hodgkin lymphoma and sued Bayer, arguing the company had failed to warn consumers that glyphosate, Roundup’s active ingredient, posed a cancer risk. A Missouri jury agreed and awarded him $1.25 million in 2023. A state appeals court upheld the verdict. The Supreme Court reversed it.

The ruling: Writing for a 7-2 majority, Justice Brett Kavanaugh held that the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) expressly preempts state tort claims that would impose labeling requirements “in addition to or different from” those required under federal law. Because the Environmental Protection Agency has approved Roundup’s label without a cancer warning and has maintained that glyphosate is unlikely to cause cancer in humans when used as directed, no state court can hold Bayer liable for the absence of that warning. The majority framed this as a matter of federal uniformity: pesticide labels must say the same thing nationwide, and a state jury cannot effectively rewrite them.

The dissent: Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch. Jackson wrote that the majority’s interpretation “unjustifiably closes the courthouse doors to state tort plaintiffs” and departs from the near-unanimous view of state and federal courts that had previously rejected the preemption argument.

What FIFRA Preemption Means

FIFRA preemption is the legal principle, now affirmed by the Supreme Court, that federal pesticide labeling law supersedes state-level requirements, including those imposed through civil litigation. If the EPA approves a pesticide label without a cancer warning, no state can effectively mandate one, whether through regulation or through a jury verdict.

The EPA’s label approval becomes the ceiling of accountability, not a floor. A company that obtains federal label approval is insulated from state failure-to-warn claims, regardless of what subsequent science shows or what juries conclude about harm. The only remaining avenue to challenge a label is to petition the EPA directly, a process that operates on agency timelines and is subject to political pressure from the same administration that argued Bayer’s position before the court.

How This Relates to the Farm Bill Fight

The Farm Bill liability shield that advocates successfully stripped from the House-passed bill in April would have codified, in statute, protection for pesticide manufacturers from failure-to-warn lawsuits when their products complied with EPA labeling rules. It would also have preempted states from setting stricter warning requirements. Critics called it a legislative gift to Bayer, written to resolve through Congress what the company had failed to resolve in court.

The Supreme Court has now resolved it through the courts instead. The Monsanto v. Durnell ruling establishes FIFRA preemption as a matter of constitutional interpretation, not just statutory preference. Congress could repeal a Farm Bill liability provision. Overturning a Supreme Court preemption doctrine requires either a new case or legislation amending the underlying federal law.

The Farm Bill fight preserved the legal status quo as of April 2026. The Supreme Court changed it in June 2026. The sequencing is not coincidental. The Trump administration’s Solicitor General argued before the court in support of Bayer’s position, and the ruling reflects that advocacy. Bayer achieved through federal preemption doctrine what its lobbyists could not achieve through the legislative process.

Why the Ruling Extends Beyond Roundup

The glyphosate debate centers on a compound whose carcinogenicity remains contested between U.S. regulatory agencies and international bodies. The International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” in 2015. The EPA concluded in 2020 that it is unlikely to cause cancer, though the Ninth Circuit Court of Appeals found that analysis inadequately explained and ordered a revised assessment. That revised EPA evaluation is expected in fall 2026.

The ruling’s reach extends well beyond glyphosate. FIFRA governs all pesticides registered for use in the United States. That includes pesticides with fluorinated chemistries, including compounds in the PFAS (per- and polyfluoroalkyl substance) family, some of which have been approved for agricultural use under FIFRA registration. PFAS compounds have been linked in peer-reviewed research to immune disruption, thyroid disease, and certain cancers; the EPA has proposed rescinding Biden-era drinking water limits for four of them as of May 2026.

Applied to PFAS-based pesticides, the court’s preemption logic would work identically: if the EPA approves a label without a health warning, state failure-to-warn suits are blocked. Legal analysts noted after the ruling that medical devices, cosmetics, and certain food-contact substances operate under federal labeling regimes structured similarly to FIFRA, and that the preemption doctrine could narrow liability exposure in those industries as well. Agricultural industry groups filed amicus briefs in the case in support of Bayer, signaling that the ruling’s implications were understood to extend beyond a single product.

FIFRA preemption, as now construed, transforms EPA label approval from a regulatory minimum into a liability shield. Any compound that clears federal label registration is insulated from state tort accountability, regardless of what science later shows. What remains is the EPA itself, an agency whose glyphosate review has been politically influenced across multiple administrations and whose current leadership has proposed rolling back restrictions on multiple agricultural chemicals.

What Remains for Plaintiffs

The ruling does not eliminate all legal pathways. As Earthjustice notes, design defect claims, which argue that the product itself was negligently formulated rather than that the label was inadequate, may survive preemption analysis. Those claims are harder to litigate, require different expert testimony, and have not yet been tested at the appellate level under this ruling.

Bayer’s proposed $7.25 billion class-action settlement, covering current and future glyphosate claimants, remains pending. A final approval hearing is scheduled for July 9, 2026 in Missouri state court. The settlement would compensate plaintiffs without requiring admission of liability, though the ruling substantially reduces the leverage plaintiffs hold in any negotiation.

The third avenue is Congress. Several lawmakers have announced intent to introduce legislation that would strip pesticide companies of the FIFRA preemption protections the court affirmed, effectively reversing Monsanto v. Durnell by statute. The political coalition for that legislation is uncertain; the same Republican majority that stripped the Farm Bill liability shield has not committed to anything more aggressive.

EPA rulemaking remains the most direct lever. If the agency’s revised glyphosate evaluation, expected this fall, finds a credible cancer risk and requires a warning label, the preemption argument inverts: state tort suits would then align with, rather than contradict, the federal label. That outcome depends on the EPA producing a scientifically defensible evaluation under an administration that has simultaneously invoked the Defense Production Act to guarantee the domestic glyphosate supply.

Who Holds Pesticide Makers Accountable Now

The practical effect of Monsanto v. Durnell is to concentrate pesticide accountability into a single federal agency subject to influence from the administrations that appoint its leadership, the industries it regulates, and the political coalitions those industries support. State attorneys general, state legislatures, and state juries, each historically a check on federal agency capture, are now preempted from the failure-to-warn space entirely.

For agricultural food systems, this matters beyond any single compound. The accountability pressure that state litigation created was partly responsible for making glyphosate’s risk profile a public and scientific debate at all. Without it, the incentives favor label approval over warning requirements, because label approval now functions as a liability shield.

The ruling comes as the same administration that argued Bayer’s position before the court continues to expand glyphosate application on federal lands, propose rollbacks of PFAS water protections, and reduce funding for programs connecting local farms to institutional food buyers. Regulatory and legal accountability for agricultural chemical exposure is narrowing, and the tools available to reverse that are fewer now than they were a week ago.